Efficacy of olanzapine monotherapy in the treatment of bipolar depression with varying degrees of manic symptoms

被引：0
|
作者：
Katagiri, H. [1 ]
Tohen, M. [2 ]
Fujikoshi, S. [1 ]
Xue, H. [3 ]
Kanba, S. [4 ]
机构：
[1] Eli Lilly Japan KK, Lilly Res Labs, Kobe, Hyogo, Japan
[2] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA
[3] Lilly Suzhou Pharmaceut Co Ltd, Shanghai Branch Med, Shanghai, Peoples R China
[4] Kyushu Univ, Dept Neuropsychiat, Fukuoka 812, Japan
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70587-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.d.016
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [1] Efficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features
    Tohen, Mauricio
    Kanba, Shigenobu
    McIntyre, Roger S.
    Fujikoshi, Shinji
    Katagiri, Hideaki
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2014, 164 : 57 - 62
  • [2] Efficacy of olanzapine monotherapy in acute bipolar depression: A pooled analysis of controlled studies
    Tohen, M.
    Katagiri, H.
    Fujikoshi, S.
    Kanba, S.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2013, 149 (1-3) : 196 - 201
  • [3] Manic/hypomanic symptoms in bipolar depression
    Tohen, M.
    [J]. BIPOLAR DISORDERS, 2013, 15 : 19 - 19
  • [4] Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder
    Katagiri, Hideaki
    Takita, Yasushi
    Tohen, Mauricio
    Higuchi, Teruhiko
    Kanba, Shigenobu
    Takahashi, Michihiro
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (05) : 701 - 713
  • [5] Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression
    Tohen, M
    Vieta, E
    Calabrese, J
    Ketter, TA
    Sachs, G
    Bowden, C
    Mitchell, PB
    Centorrino, F
    Risser, R
    Baker, RW
    Evans, AR
    Beymer, K
    Dubé, S
    Tollefson, GD
    Breier, A
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (11) : 1079 - 1088
  • [6] Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study
    Wang, Man
    Tong, Jian-hua
    Huang, De-sheng
    Zhu, Gang
    Liang, Guang-ming
    Du, Hong
    [J]. PSYCHOPHARMACOLOGY, 2014, 231 (14) : 2811 - 2818
  • [7] Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study
    Man Wang
    Jian-hua Tong
    De-sheng Huang
    Gang Zhu
    Guang-ming Liang
    Hong Du
    [J]. Psychopharmacology, 2014, 231 : 2811 - 2818
  • [8] Efficacy of olanzapine in patients with bipolar depression
    Bardenshteyn, L.
    Beglyankin, N.
    Slavgorodsky, Y.
    Shcherbakova, I.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 177 - 178
  • [9] Olanzapine in the treatment of bipolar depression
    Tohen, M
    Vieta, E
    Kettter, T
    Centorino, F
    Calabrese, J
    Sachs, G
    Bowden, CL
    Risser, RC
    Baker, RW
    Evans, AR
    Dube, S
    Tollefson, GD
    Breier, A
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S238 - S239
  • [10] COST EFFECTIVENESS OF LURASIDONE, QUETIAPINE, AND OLANZAPINE MONOTHERAPY IN THE TREATMENT OF BIPOLAR I DISORDER DEPRESSION
    Bhagvandas, N. S.
    Hay, J. W.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A188 - A188
12345